- Info
- Significant Ownership
- Insider Ownership
- Insider Trading
- Financials
- Holders
Significant Ownership of AbbVie Inc.
- Signature - Title
- /s/ Scott T. Reents - Scott T. Reents, Executive Vice President, Chief Financial Officer
- Location
- North Chicago, IL
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by AbbVie Inc..
Follow Filing Activity
Follow AbbVie Inc. and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of AbbVie Inc.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| XLO | Xilio Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 9% | $3,304,348 | 4,347,826 | AbbVie Inc. | 11 Feb 2025 |
Schedules 13D/G Reported by AbbVie Inc.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.